Page last updated: 2024-09-02

tadalafil and Scleroderma, Limited

tadalafil has been researched along with Scleroderma, Limited in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chin, K; Damico, R; Girgis, RE; Hassoun, PM; Khair, RM; Kolb, TM; Mathai, SC; Mercurio, V; Minai, OA; Mukherjee, M; Sato, T; Tedford, RJ; Torres, F; Zamanian, RT	1

Trials

1 trial(s) available for tadalafil and Scleroderma, Limited

Article	Year
Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. American journal of respiratory and critical care medicine, 2018, 02-01, Volume: 197, Issue:3 Topics: Aged; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Observer Variation; Phenylpropionates; Prospective Studies; Pyridazines; Scleroderma, Limited; Tadalafil; Treatment Outcome; Ventricular Dysfunction, Right	2018

Article

Year

Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

American journal of respiratory and critical care medicine, 2018, 02-01, Volume: 197, Issue:3

Topics: Aged; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Observer Variation; Phenylpropionates; Prospective Studies; Pyridazines; Scleroderma, Limited; Tadalafil; Treatment Outcome; Ventricular Dysfunction, Right

2018